WOODCLIFF LAKE, N.J., April 17, 2018 -- Catalogic Software today announced the release and general availability of DPX 4.5.2, a major update to Catalogic’s data protection software that has been an industry leader in providing state-of-the-art data recovery and backup success rates for over twenty years.
“This release continues the wave of updates and innovation in DPX that we began last year,” said Ethan Blynn, Vice President and General Manager of the DPX business unit. “With this release we are introducing a major architectural update to DPX with our software-defined vStor data repository.”
The vStor data repository is a true next generation backup repository created using modern open-source components and micro-services. It provides a scalable and efficient software-defined backup target that can be built using any block-storage device.
“With this release, we’re leap-frogging other vendors that still rely on specific hardware,” said Blynn. “We’re giving our customers the freedom and flexibility they don’t get from proprietary and costly backup appliances.”
The vStor repository can be as small as a single self-contained virtual machine, perfect for small or remote office scenarios, and can scale up to hundreds of terabytes. It includes deduplication and compression for storage savings, and vStor nodes can replicate to each other for disaster recovery or data distribution.
“Customers no longer have to pick from a set of fixed form factors,” Blynn explained. “They are free to build their backup targets in whatever way meets their performance, efficiency and cost requirements. And the vStor software is part of their DPX license. There are no additional licenses required.”
In addition to the vStor repository, the DPX 4.5.2 adds several other features that DPX customers have requested. A full list of updates is in the What’s New document. Catalogic is also presenting two webinars on April 19th, at 10:00 a.m. and 2:00 p.m. EST which will provide details of the new release.
Key Links
About Catalogic Software
Founded in 1996 and with thousands of customers worldwide, Catalogic’s mission is to enable IT organizations to better protect and leverage their copy data, delivering significant reductions to CAPEX and OPEX while providing superior services to the business. With its software products, Catalogic helps clients Manage, Orchestrate and Analyze their Copy Data across their enterprise and cloud in support of mission critical IT functions including disaster recovery, test/dev, DevOps, next generation data protection, and business analytics. Learn more at www.catalogicsoftware.com.
Press Inquiries:
Joanne Hogue
Smart Connections PR
410.658.8246


How Marco Pharma International Preserves German Homeopathic Traditions in America
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 



